Conference Reports for NATAP

21st Conference on Retroviruses and Opportunistic Infections Boston, MA March 3 - 6, 2014 Back

ABT-530, an HCV NS5A Inhibitor With Potent Pangenotypic Activity and High Genetic Barrier to Resistance       Reported by Jules Levin CROI 2014 March 3-6 Boston, MA   Teresa Ng, Preethi Krishnan, Warre